Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 7 | Model 6 | ||
---|---|---|---|---|---|---|---|---|
Fig S8 | Fig S9 | Fig S10 | Fig S11 | Fig S12 | Fig S14 | Fig S13 | 95% CI | |
Factora,b,c,d,e,f,g,h,i | ||||||||
b_Ps_n | ||||||||
Pseudomonas gut overgrowth | 1 | 1 | 1 | 1 | 1 | 1 | 1 | Constrained |
ppap | 1.11** | 0.97** | 0.97** | 1.00** | 0.95** | 0.27 to 1.61 | ||
_cons | − 5.18*** | − 5.19*** | − 5.38*** | − 6.00*** | − 6.00*** | − 6.05*** | − 6.05*** | − 6.6 to − 5.4 |
b_Ac_n | ||||||||
Acinetobacter GO | 1 | 1 | 1 | 1 | 1 | 1 | 1 | Constrained |
ppap | 0.6 | 0.46 | 0.48 | 0.44 | 0.47 | − 0.51 to 4639 | ||
_cons | − 6.74*** | − 6.74*** | − 6.83*** | − 7.38*** | − 7.44*** | − 7.47*** | − 7.47*** | − 8.0 to − 7.0 |
v_Ps_n | ||||||||
Pseudomonas gut overgrowth | 0.67*** | 0.67*** | 0.71*** | 0.80*** | 0.80*** | 0.81*** | 0.81*** | 0.51 to 1.09 |
mvp90 | 0.55* | 0.54* | 0.49* | 0.43 | 0.43 | 0.48* | 0.49* | 0.03 to 0.92 |
non_D | − 0.37* | − 0.58*** | − 0.61*** | − 0.60*** | − 0.60*** | − 0.54*** | − 0.54*** | − 0.79 to − 0.31 |
_cons | − 3.63*** | − 3.63*** | − 3.56*** | − 4.17*** | − 4.17*** | − 4.24*** | −4.25*** | − 4.7 to − 3.7 |
v_Ac_n | ||||||||
Acinetobacter gut overgrowth | 0.73*** | 0.73*** | 0.74*** | 0.83*** | 0.83*** | 0.83*** | 0.83*** | + 0.66 to 1.01 |
mvp90 | 0.79* | 0.79* | 0.73 | 0.71 | 0.69 | 0.71 | 0.7 | − 0.12 to 1.55 |
non_D | − 0.35 | − 0.31 | − 0.33 | − 0.27 | − 0.21 | − 0.17 | − 0.17 | − 0.56 to 0.23 |
_cons | − 5.13*** | − 5.13*** | − 5.06*** | − 5.79*** | − 5.85*** | − 5.88*** | − 5.87*** | − 6.8 to −4.9 |
Pseudomonas gut overgrowth | ||||||||
TAP | − 0.65** | − 0.65** | − 0.67*** | − 0.68*** | − 0.68*** | − 0.47* | − 0.57*** | − 0.91 to − 0.29 |
a_S | − 1.34*** | − 1.33*** | − 1.20*** | − 1.01*** | − 1.00*** | − 0.94*** | − 0.93*** | − 1.46 to − 0.46 |
eap | − 0.21 | |||||||
ppap | 0.27 | 0.27 | ||||||
non_D | −0.33 | |||||||
los7 | 1.03*** | 1.03*** | 0.96*** | 0.97*** | 0.53 to 1.45 | |||
trauma50 | 0.04 | 0.03 | 0.02 | − 0.33 to 0.36 | ||||
CC | 0.56** | 0.56** | 0.08 to 1.10 | |||||
Acinetobacter gut overgrowth | ||||||||
TAP | − 0.25 | − 0.25 | − 0.27 | − 0.27 | − 0.5 | − 0.58 | − 0.43 | − 1.04 to 0.15 |
a_S | − 1.26* | − 1.27* | − 1.21* | − 1.04* | − 0.85 | − 0.8 | − 0.82 | − 1.83 to 0.19 |
eap | 0.25 | |||||||
ppap | 0.1 | 0.1 | ||||||
non_D | 0.06 | |||||||
los7 | 1.15*** | 1.01*** | 0.99*** | 0.98*** | 0.41 to 1.54 | |||
trauma50 | 1.09*** | 1.04*** | 1.04*** | 0.47 to 1.62 | ||||
CC | 0.42 | 0.42 | − 0.22 to 1.22 | |||||
Error terms | ||||||||
var(e.Ps_GO) | 1.32* | 1.32* | 1.17** | 0.76** | 0.76** | 0.71** | 0.72** | 0.36 to 1.47 |
var(e.Ac_GO) | 2.66*** | 2.66*** | 2.56*** | 1.92*** | 1.62*** | 1.60*** | 1.60*** | 1.01 to 2.48 |
Model fitj | ||||||||
AIC | 3345.94 | 3344.15 | 3329.29 | 3274.57 | 3261.55 | 3259.1 | 3255.53 | |
N | 22 | 20 | 20 | 22 | 24 | 28 | 26 | |
Groups (n) | 334 | 334 | 334 | 334 | 334 | 334 | 334 | |
Clusters (n) | 213 | 213 | 213 | 213 | 213 | 213 | 213 |